Rubicon Research Ltd

NSE: RUBICON · BSE: 544578 · Pharmaceuticals & Biotechnology · 38 announcements

Share price: ₹1,570.00
Market cap: ₹25,989 Cr
Revenue (annual): ₹1,754 Cr
Net profit (annual): ₹246.7 Cr
P/E (TTM): 90.2×Sector 47.4×
Promoter holding: 59.76%-0.10% QoQ
FII holding: 7.52%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 5 Earnings Call 3 Promoter Selling 2 Merger & Restructuring 2 Annual General Meeting 2 Management Change 1 Financial Results 1 Employee Stock Options 1 Dividend 1 Capital Structure Change 1 Board Meeting Date 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

28 Aug 2026 18:43 IST BSE

Promoter Selling

Rubicon Research Promoter Selling: ₹2,325 Cr

Promoter General Atlantic Singapore RR Pte Ltd sold equity shares in market transactions aggregating to Rs. 232.50 Crore across two tranches.

Value: ₹2,325 Cr

Read the filing ↗

27 Aug 2026 09:18 IST BSE

Promoter Selling

Rubicon Research Promoter Selling

Promoter General Atlantic Singapore RR Pte. Ltd. sold 1,40,00,000 shares (8.45% stake) of Rubicon Research Ltd via on-market sales on August 25 and 26, 2026.

Read the filing ↗